Status:
COMPLETED
Radiofrequency-based Speckle Tracking Echocardiography to Evaluate Diastolic Function
Lead Sponsor:
University of Michigan
Collaborating Sponsors:
Pixel Velocity, Inc. / Epsilon Imaging
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Heart Failure, Diastolic
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
The purpose of this study is to evaluate a novel ultrasound system's ability to assess the relaxing properties of the heart compared to current techniques.
Eligibility Criteria
Inclusion
- Patients scheduled to undergo a clinically indicated left heart cardiac catheterization will be recruited for the study.
Exclusion
- Suspected acute ST elevation myocardial infarction.
- Acute coronary syndrome with active ongoing chest pain
- Known or suspected acute aortic dissection
- Known or suspected cardiac tamponade
- Known history of unoperated constrictive pericarditis
- Known or suspected severe aortic stenosis or severe mitral regurgitation
- Heart rhythm other than sinus rhythm on pre-cath EKG
- Age \< 18 years old
- Unable to provide informed consent
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01182805
Start Date
August 1 2010
End Date
December 1 2010
Last Update
October 16 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan Cardiovascular Center
Ann Arbor, Michigan, United States, 48109-5853